Teladoc Stock: Buy, Sell or Hold In 2022?

·4 min read
Teladoc Stock: Buy, Sell or Hold In 2022?

At the top of that list is Teladoc Health (NYSE: TDOC), the telehealth company that saw its usage and stock price surge during the height of the pandemic as patients needing medical care turned to its platform to see doctors virtually. Considering this backdrop, investors could expect to see Teladoc's results tapering off, fitting the company neatly into the pandemic stock narrative. On its own, the 81% revenue growth is excellent, but it's even more impressive considering that Q3 of 2020 featured growth of 108%.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting